—

Novartis AG (NOVN.SW) — the peer cohort

As of 2026-11-21 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Novartis AG ranks 16 of 16 in its cohort on the Closelooknet composite (58/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
NOVN.SW Novartis AG 58 74 82 39 ok 6.7%
HALO Halozyme Therapeutics Inc 72 68 94 50 info 31.8%
ONC BeOne Medicines AG 66 87 67 29 ok 8%
REGN Regeneron Pharmaceuticals Inc 65 90 72 47 neutral 7.2%
UCB.BR UCB SA 65 77 71 42 info 7.2%
ARGX.BR Argen-X 64 80 73 25 ok 7.8%
LLY Eli Lilly and Company 64 88 90 22 bear 8.7%
ANN.AU Ansell Ltd 63 96 47 49 ok 2.7%
ARGX argenx NV ADR 63 71 73 25 ok 13.7%
ROVI.MC Laboratorios Farmaceuticos ROVI 63 59 74 43 info 26%
ORNAV.HE Orion Oyj A 63 95 84 27 ok 3.5%
ORNBV.HE Orion Oyj B 63 95 84 27 ok 3.5%
RIGL Rigel Pharmaceuticals Inc 63 73 89 77 info 23.8%
SAN.PA Sanofi SA 63 77 69 59 bull 4.6%
DXCM DexCom Inc 62 69 78 33 watch 14.3%
HQY HealthEquity Inc 62 68 70 40 info 14.1%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-21

Quick answers

Who are Novartis AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR), Argen-X (ARGX.BR), Eli Lilly and Company (LLY), Ansell Ltd (ANN.AU), argenx NV ADR (ARGX) and others, as of 2026-11-21.

How does NOVN.SW score against its peers?

Novartis AG's composite reads 58/100, ranking 16 of 16 in its cohort as of 2026-11-21; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe